Berdeja JG, Lin Y, Raje N, et al. Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy. ASH 59th Annual Meeting & Exhibition, abstract 740.
Fase I-onderzoek naar IL-10-producerende anti-CD19 CAR T-cellen bij r/r B-cel ALL
dec 2025 | Leukemie